Zoetis, the largest animal-health company, received an upgrade on Monday ahead of the expected regulatory approval of Simparica Trio, an oral canine drug that is expected to generate big sales.

source https://finance.yahoo.com/m/3b62f733-6954-3008-a535-d77283017d3b/buy-zoetis-stock-because-its.html?.tsrc=rss